Prostate and lung cancer are projected to emerge as the most common malignancies among persons living with HIV by 2030.
As mortality has decreased among persons with HIV, patients are living longer; the proportion over the age of 45 is projected to increase to 69.1% by 2030. As a result, AIDS-defining cancers (Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer) are expected to be less common and non–AIDS-defining cancers to become more frequent. To project cancer incidence rates and burden among persons with HIV in the U.S. through 2030, investigators analyzed data from the National Cancer Institute HIV/AIDS Cancer Match Study (http://www.hivmatch.cancer.gov).
The number of adults living with HIV is estimated to increase from 1.06 million in 2006 to 1.17 million in 2018 and decrease to 1.09 million by 2030; an estimated 21.4% will be older than 65 and …
Reviewing Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)